๐ S2B Scale-up Case: JNP Mediโs 1,865x Growthย
JNP Medi, a digital clinical trial and data management service provider, achieved an astonishing 1,865x growth in just two years. This success was driven by strategic investments through Shinhanโs dedicated fund and a global market expansion strategy.
๐ JNP Mediโs Growth Achievements
โ
Total Investment Secured: KRW 14 billion ($10M)
โ
2023 Revenue: KRW 1 billion ($750K)
โ
Corporate Valuation Growth: 1,865x increase in two years
๐ The valuation graph shows a steep rise, particularly in years 3โ4, reaching nearly KRW 50 billion ($37M).
๐ฅ Two-Year Growth Program: Incubation-Driven Strategy
JNP Mediโs rapid scale-up was enabled by a two-year customized support program, focusing on incubation and strategic investments.
๐ฏ Key Support Initiatives
โ๏ธ Business & R&D strategy development tailored to each growth stage
โ๏ธ Direct & indirect investments through Shinhanโs dedicated fund
โ๏ธ Global expansion support via partnerships & marketing initiatives
This structured support provided the foundation for JNP Medi to scale quickly and enter global markets.
๐ Global Expansion & Future Outlook
JNP Medi is rapidly expanding in the digital clinical trial and data management sector worldwide. Investment and marketing support through Shinhanโs dedicated fund have been key drivers of its international growth.
This case clearly demonstrates how structured support and investment strategies can drive hypergrowth for startups.
๐ Key Takeaways for Startup Scale-up
โ
Develop phased growth strategies for structured business expansion
โ
Secure stable funding by collaborating with trusted investment partners
โ
Leverage marketing & partnerships to penetrate global markets
JNP Mediโs unprecedented growth in just two years proves that focused support and strategic investment can lead to exponential startup success. ๐
๐ S2B Scale-up Case: JNP Mediโs 1,865x Growthย
JNP Medi, a digital clinical trial and data management service provider, achieved an astonishing 1,865x growth in just two years. This success was driven by strategic investments through Shinhanโs dedicated fund and a global market expansion strategy.
๐ JNP Mediโs Growth Achievements
โ Total Investment Secured: KRW 14 billion ($10M)
โ 2023 Revenue: KRW 1 billion ($750K)
โ Corporate Valuation Growth: 1,865x increase in two years
๐ The valuation graph shows a steep rise, particularly in years 3โ4, reaching nearly KRW 50 billion ($37M).
๐ฅ Two-Year Growth Program: Incubation-Driven Strategy
JNP Mediโs rapid scale-up was enabled by a two-year customized support program, focusing on incubation and strategic investments.
๐ฏ Key Support Initiatives
โ๏ธ Business & R&D strategy development tailored to each growth stage
โ๏ธ Direct & indirect investments through Shinhanโs dedicated fund
โ๏ธ Global expansion support via partnerships & marketing initiatives
This structured support provided the foundation for JNP Medi to scale quickly and enter global markets.
๐ Global Expansion & Future Outlook
JNP Medi is rapidly expanding in the digital clinical trial and data management sector worldwide. Investment and marketing support through Shinhanโs dedicated fund have been key drivers of its international growth.
This case clearly demonstrates how structured support and investment strategies can drive hypergrowth for startups.
๐ Key Takeaways for Startup Scale-up
โ Develop phased growth strategies for structured business expansion
โ Secure stable funding by collaborating with trusted investment partners
โ Leverage marketing & partnerships to penetrate global markets
JNP Mediโs unprecedented growth in just two years proves that focused support and strategic investment can lead to exponential startup success. ๐